• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 19 Feb 2026

ROMJ: First Harvest at Cascadia; On Time and On Budget


Rubicon Organics, Inc. (ROMJ:TSX) | 0 0 0.0%


  • Atrium Research
    • Nicholas Cortellucci, CFA

    • 4 pages


 

What you need to know: • ROMJ announced that it has completed the first harvest of cannabis at its new Cascadia facility, with the ramp up being on time and on budget. • We believe this strong execution speaks to management’s reputation and operational efficiency, building on its already positive track record. • Flagship-quality cannabis is expected to be reached in mid-2026, and management foresees opportunities to increase capacity further. • This week, Organigram announced the acquisition of German firm, Sanity Group for 11-13x 2026E EBITDA vs. ROMJ at 3.6x. This morning, Rubicon Organics Inc. (ROMJ:TSXV, ROMJF:OTCQX) announced that it has completed the first harvest of cannabis from its new Cascadia facility in Hope, British Columbia. We view this update as a solid positive given that it was completed on time and on budget, building on management’s already strong reputation. ROMJ stock has been stable around these levels, trading at just 3.6x 2026E ahead of another year of >20% revenue growth. We remind readers that we recently conducted an interview with ROMJ’s CEO Margaret Brodie; watch it here. We are maintaining our BUY rating and $1.00/share target price on Rubicon Organics. ROMJ indicated that Cascadia is now fully planted, demonstrating operational execution. Since June 2025, ROMJ prepared the site for commercial production through targeted capital investments, securing required licenses, commissioning the facility, and onboarding more than 30 operations team members. This includes modifications to the facility layout and installation of new grow tables, both of which are expected to improve efficiency and increase annual production. Additionally, management highlighted the potential to further increase the production capacity at the facility over time as crop performance data is collected and selections from its genetics library are optimized. Initial harvests are expected to generate revenue in Q2, with flagship-brand quality being reached in mid-2026. We remind readers that Cascadia has an estimated production capacity of 4,500kg of premium cannabis annually (could be higher), boosting ROMJ’s capacity by 40%.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

ROMJ: First Harvest at Cascadia; On Time and On Budget


Rubicon Organics, Inc. (ROMJ:TSX) | 0 0 0.0%


  • Published: 19 Feb 2026
  • Author: Nicholas Cortellucci, CFA
  • Pages: 4
  • Atrium Research


What you need to know: • ROMJ announced that it has completed the first harvest of cannabis at its new Cascadia facility, with the ramp up being on time and on budget. • We believe this strong execution speaks to management’s reputation and operational efficiency, building on its already positive track record. • Flagship-quality cannabis is expected to be reached in mid-2026, and management foresees opportunities to increase capacity further. • This week, Organigram announced the acquisition of German firm, Sanity Group for 11-13x 2026E EBITDA vs. ROMJ at 3.6x. This morning, Rubicon Organics Inc. (ROMJ:TSXV, ROMJF:OTCQX) announced that it has completed the first harvest of cannabis from its new Cascadia facility in Hope, British Columbia. We view this update as a solid positive given that it was completed on time and on budget, building on management’s already strong reputation. ROMJ stock has been stable around these levels, trading at just 3.6x 2026E ahead of another year of >20% revenue growth. We remind readers that we recently conducted an interview with ROMJ’s CEO Margaret Brodie; watch it here. We are maintaining our BUY rating and $1.00/share target price on Rubicon Organics. ROMJ indicated that Cascadia is now fully planted, demonstrating operational execution. Since June 2025, ROMJ prepared the site for commercial production through targeted capital investments, securing required licenses, commissioning the facility, and onboarding more than 30 operations team members. This includes modifications to the facility layout and installation of new grow tables, both of which are expected to improve efficiency and increase annual production. Additionally, management highlighted the potential to further increase the production capacity at the facility over time as crop performance data is collected and selections from its genetics library are optimized. Initial harvests are expected to generate revenue in Q2, with flagship-brand quality being reached in mid-2026. We remind readers that Cascadia has an estimated production capacity of 4,500kg of premium cannabis annually (could be higher), boosting ROMJ’s capacity by 40%.

More Content

More Content

ROMJ: Lots of Positive Developments; Reiterating Bullish Stance

Companies: Rubicon Organics, Inc.

Atrium Research

ETST: F3Q26 Earnings - Increasing Visibility into Accelerating Growth and Stronger Financial Performance

Companies: EARTH SCIENCE TECH (ETST:NYSE)Earth Science Tech, Inc. (ETST:OTC)

Zacks Small Cap Research

Q4/25 Recap: All Our Research in One Place!

Companies: NIM DWS SPA CUU LIO REG SCZ DRX AUAU ARG OMG BQE GEC CUU DWS DNG EDG GTCH KRI KRI MOO NIM REG RIO ROMJ SPA SBIO LVG NKG NFLD FRG NAMM SCZ CAPT LIO MSA APM MTT FISH FCLI

Atrium Research

In line

Companies: Photocure ASA (PHO:OSL)PHOTOCURE (PHO:STO)

ABG Sundal Collier

ROMJ: Strong Growth in Q3; Various Catalysts Ahead

Companies: Rubicon Organics, Inc.

Atrium Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2026

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Alternative Resource Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Morphose Capital Partners
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS Research Group
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Curious Compounder
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • ISTAR Capital
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • ISTAR Capital
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In